Breeze Meds vs NativeMed
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Breeze Meds
Best for compounded GLP-1 access with named prescribers and 4-pharmacy networkStarting at $199/mo
NativeMed
Best for buyers comfortable with sub-$200 promotional compounded GLP-1 pricing who can verify pharmacy partner identity directly with NativeMed support before subscribingStarting at $149/mo
Side-by-Side Comparison
| Feature | Breeze Meds | NativeMed |
|---|---|---|
| Overall Score | ✓7.3/10 | 7.1/10 |
| Starting Price | $199/mo | ✓$149/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.6 ★ /5 |
| Features | ✓6 features | 4 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Breeze Meds
Pros
- ✓Available in all 50 US states
- ✓LegitScript certified seal displayed in footer
- ✓Publicly named medical team with NPI numbers: Dr. Ana Lisa Carr MD (NPI 1689841744) and Dr. Kelly Tenbrink MD (NPI 1346482684)
- ✓Four named 503A pharmacy partners: Belmar Pharma Solutions, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx
- ✓Both injectable and oral formats available for semaglutide and tirzepatide
- ✓No FDA warning letters or litigation on record as of 2026-04-09
Cons
- ✗Runs on the same Lion MD clinician network and the same 4 compounding pharmacies as Care Bare Rx and Synergy Rx — if you're comparing the three brands, be aware you're comparing three storefronts on top of one underlying operation, not three independent providers
- ✗Compounded medications are not FDA-approved
- ✗Compounded vs. brand-name drug sourcing is ambiguously disclosed on the product pages
- ✗Terms of Service page returns a 404 (Privacy Policy is present) — a procedural transparency gap
- ✗Insurance acceptance is not clearly disclosed beyond FSA/HSA eligibility
NativeMed
Pros
- ✓LegitScript certified per the homepage footer (independently verifiable)
- ✓Promotional pricing publicly displayed: $149/mo semaglutide, $183/mo tirzepatide (sale from $299/$399 regular)
- ✓Async questionnaire workflow with synchronous visit triggered when state law requires it
Cons
- ✗Pharmacy partners are NOT publicly named — material gap for YMYL disclosure (described only as 'USA-based pharmacies' / 'accredited pharmacies')
- ✗States served list is not publicly enumerated
- ✗Pricing displayed as promotional sale price — readers should confirm whether the $149/$183 holds beyond the first month or escalates to the $299/$399 'regular' price
- ✗Trustpilot reviews displayed on homepage — we do NOT cite Trustpilot as a primary source per editorial policy
Our Verdict
Breeze Meds edges out NativeMed with a higher overall score of 7.3/10 and is particularly strong for compounded GLP-1 access with named prescribers and 4-pharmacy network. NativeMed remains a solid alternative, especially if you're looking for buyers comfortable with sub-$200 promotional compounded GLP-1 pricing who can verify pharmacy partner identity directly with NativeMed support before subscribing.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.